Arogya Legal- Health Laws Specialists Law Firm’s Post

Top Health Laws & Policy Updates 08 November 2024 #NPPA #Reduction #MRP #CancerDrug #GST #CustomDuty The National Pharmaceutical Pricing Authority (NPPA) has directed drug manufacturers to reduce the maximum retail price (MRP) of three crucial cancer drugs i.e., Trastuzumab Deruxtecan, Osimertinib, and Durvalumab. This is in line with reduction of customs duty and GST rates on these medications. Source: bit.ly/4fBQ3Dd #Pharma #CopyrightInfringement #Label #Injunction Delhi High Court has granted a permanent injunction against a pharma company which had imitated the design and presentation of a drug manufactured by another pharma company. This ruling highlights the requirement for pharma companies to ensure a distinctive packaging to avoid copyright Infringement claims.  Source: bit.ly/40AprhH   #OnlineDelivery #Restriction #Pharma #PatientSafety #DGCI #AIOCD The All India Organization of Chemists and Druggists (AIOCD) has urged the Drug Controller General of India (DCGI) to restrict a partnership between a rapid delivery platform and an e-pharmacy, citing concerns over regulatory and quality compliance issues that could potentially jeopardize patient safety. Source: bit.ly/4fDJEqS   #Drug #Quality #QRcode #Consumer #Information The Himachal Pradesh High Court has directed the state government to implement a QR code system to assess the quality of medicines in the state. This QR code will provide consumers with key information about the medicine, including production and expiry dates, unit details, batch numbers, and component specifics in order to enhance consumer awareness and transparency in medicine quality. Source: bit.ly/3YE20Bw   #UK #Launching #Pandemic #WarningSystem #Genomics UK government is set to launch ‘World-First’ Genomics-Led pandemic warning system. The system will utilize the technology to flag and monitor potential outbreaks of bacterial or viral diseases. Source: bit.ly/4fBdyw6

To view or add a comment, sign in

Explore topics